Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of LBVC in Healthy Infants
NCT03169725Phase 3Completed
- Sponsor
- LG Chem
- Start
- May 2017
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of inactivated poliomyelitis vaccine (Sabin strains) in poliomyelitis, sponsored by LG Chem. Started May 2017; status: completed.
02
Drugs
inactivated poliomyelitis vaccine (Sabin strains)
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03169725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03169725.